Windlas Biotech Limited
MainboardlistedWINDLASINE0H5O01029- DRHP filed17 May 21
- RHP filed30 Jul 21
- Open04 Aug 21
- Close06 Aug 21
- Listed16 Aug 21
Issue
- Price band
- ₹448–460
- Issue price
- ₹460
- Face value
- ₹5
- Lot size
- 30
- Issue size
- ₹401.54 Cr
- Fresh / OFS
- ₹165 Cr / ₹236.54 Cr
- Issue type
- book built
- Registrar
- Link Intime India Private Limited
- Exchanges
- BSE, NSE
- Sector
- Healthcare
- Industry
- Pharmaceuticals
Returns
- Listing
- -11.5%
- 1 month
- -16.3%
- 3 months
- -36.5%
- 6 months
- -41.7%
- 1 year
- -53.5%
- Current (03 Nov 26)
- +91.2%
Financials · from the offer document, ₹ crore
| Period | Revenue | EBITDA | PAT | Net worth | Borrowings | Total assets |
|---|---|---|---|---|---|---|
| FY19 | 307.3 | 63.8 | 298.2 | |||
| FY20 | 328.9 | 16.2 | 338.5 | |||
| FY21 | 427.6 | 15.6 | 296.1 |
Reservation · share of the issue the offer document allocates to each category
- qib
- 50%
- nii
- 15%
- retail
- 35%
Subscription
| Category | Exchange | Times subscribed |
|---|---|---|
| nii | NSE | 7.51× |
| qib | NSE | 14.25× |
| retail | NSE | 11.67× |
| total | NSE | 11.50× |
Lead managers
DAM Capital Advisors Limited · IIFL Securities Ltd · SBI Capital Markets Limited